Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML
Authors
Bultitude, WPSchellekens, J
Szydlo, RM
Anthias, C
Cooley, SA
Miller, JS
Weisdorf, DJ
Shaw, BE
Roberts, CH
Garcia-Sepulveda, CA
Lee, J
Pearce, RM
Wilson, MC
Potter, MN
Byrne, JL
Russell, NH
MacKinnon, S
Bloor, Adrian
Patel, A
McQuaker, IG
Malladi, R
Tholouli, E
Orchard, K
Potter, VT
Madrigal, JA
Mayor NP
Marsh, SGE
Affiliation
Anthony Nolan Research Institute, Royal Free Hospital, London, UK.Issue Date
2020
Metadata
Show full item recordCitation
Chauvin M, Borys D, Botta F, Bzowski P, Dabin J, Denis-Bacelar AM, et al. OpenDose: open access resources for nuclear medicine dosimetry. J Nucl Med. 2020.Journal
Bone Marrow TransplantationDOI
10.1038/s41409-020-0858-9PubMed ID
32203258Additional Links
https://dx.doi.org/10.1038/s41409-020-0858-9Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1038/s41409-020-0858-9
Scopus Count
Collections
Related articles
- Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation.
- Authors: Zhou H, Bao X, Wu X, Tang X, Wang M, Wu D, He J
- Issue date: 2014 Jan
- Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight.
- Authors: Schetelig J, Baldauf H, Heidenreich F, Hoogenboom JD, Spellman SR, Kulagin A, Schroeder T, Sengeloev H, Dreger P, Forcade E, Vydra J, Wagner-Drouet EM, Choi G, Paneesha S, Miranda NAA, Tanase A, de Wreede LC, Lange V, Schmidt AH, Sauter J, Fein JA, Bolon YT, He M, Marsh SGE, Gadalla SM, Paczesny S, Ruggeri A, Chabannon C, Fleischhauer K
- Issue date: 2024
- Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
- Authors: Faridi RM, Kemp TJ, Dharmani-Khan P, Lewis V, Tripathi G, Rajalingam R, Daly A, Berka N, Storek J, Masood Khan F
- Issue date: 2016
- Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.
- Authors: Cooley S, Trachtenberg E, Bergemann TL, Saeteurn K, Klein J, Le CT, Marsh SG, Guethlein LA, Parham P, Miller JS, Weisdorf DJ
- Issue date: 2009 Jan 15
- Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia.
- Authors: Cooley S, Weisdorf DJ, Guethlein LA, Klein JP, Wang T, Marsh SG, Spellman S, Haagenson MD, Saeturn K, Ladner M, Trachtenberg E, Parham P, Miller JS
- Issue date: 2014 May 15